Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
CXXC5 plays a role as a transcription activator for myelin genes on oligodendrocyte differentiation.
Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: special focus on helminth-derived treatments.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration.
Effect of passive whole-body heating on central conduction and cortical excitability in multiple sclerosis patients and healthy controls.
Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine.
IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis.
ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro.
Undifferentiated MSCs are able to myelinate DRG neuron processes through p75.
Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression.
Sex-biased chromatin and regulatory cross-talk between sex chromosomes, autosomes, and mitochondria.
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
The protective effects of bioactive (RS)-glucoraphanin on the permeability of the mice blood-brain barrier following experimental autoimmune encephalomyelitis.
Variations in predicted risks in personal genome testing for common complex diseases.
[Multiple sclerosis and occupational exposures: results of an explorative study].
A pilot study on factors involved with work participation in the early stages of multiple sclerosis.
A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol.
ShcA Regulates Late Stages of T Cell Development and Peripheral CD4+ T Cell Numbers.
Comment on: Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
The effect of executive function on stress, depression, anxiety, and quality of life in multiple sclerosis.
Immune Responses to Non-Tumor Antigens in the Central Nervous System.
Neurological and psychiatric disorders as a neuroglial failure.
Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity.
The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation.
Brainstem and limbic encephalitis with paraneoplastic neuromyelitis optica.
Pages
« first
‹ previous
…
502
503
504
505
506
507
508
509
510
…
next ›
last »